Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 4OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 20Thoracic 7Genitourinary 5Gastrointestinal 4Plasma cell 2Gynecologic 2Dermatologic 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Endocrine 1CNS 1

Conditions

Somatostatinoma 5Kidney Neoplasms 5Adrenocortical Carcinoma 5Insulinoma 4Glucagonoma 4Gastrinoma 4Carcinoma, Islet Cell 4Thyroid Neoplasms 3Thyroid Carcinoma, Anaplastic 3Thyroid Cancer, Papillary 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Salivary Gland Neoplasms 3Pheochromocytoma 3Neuroendocrine Tumors 3Head and Neck Neoplasms 3Carcinoma, Medullary 3Adenocarcinoma, Follicular 3Vipoma 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neoplasms 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2

Interventions

vandetanib 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms, Male × Endocrine × Clear all
NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡